SCHEMBL22384242

SCHEMBL22384242

CC(C)(C)OC(=O)C(Cc1ccc(O)cc1)NC(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LNPEP Q9UIQ6 3/20 0.55
▸ ESRRG P62508 3/20 0.52
▸ ESRRB O95718 1/20 0.51
▸ LY96 Q9Y6Y9 1/20 0.51
▸ CTSS P25774 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ POLB P06746 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ CTSL P07711 1/20 0.47
▸ ERAP2 Q6P179 2/20 0.47
▸ ERAP1 Q9NZ08 1/20 0.47
▸ ROCK2 O75116 2/20 0.46
▸ MDM4 O15151 1/20 0.46
▸ MDM2 Q00987 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15037126 1.00 LNPEP (0.55) LNPEPESRRGESRRBLY96CTSS
SCHEMBL15096411 0.90 MAPT (0.49) LNPEPLY96POLBMAPTTDP1
SCHEMBL27616693 0.89 CTSL (0.60) LNPEPLY96CTSSCTSKPOLB
SCHEMBL19485398 0.89 MAPT (0.59) POLBMAPTTDP1CTSLROCK2
SCHEMBL7703695 0.88 LNPEP (0.53) LNPEPLY96CTSSCTSKCA1
SCHEMBL28217499 0.86 LNPEP (0.58) LNPEPLY96CTSSCTSKCA1
SCHEMBL28217498 0.86 LNPEP (0.58) LNPEPLY96CTSSCTSKCA1
SCHEMBL15019672 0.85 CA2 (0.65) LNPEPESRRGESRRBCA1CA2
SCHEMBL28535866 0.85 CA2 (0.65) LNPEPESRRGESRRBCA1CA2
SCHEMBL28294749 0.84 MAPT (0.50) POLBMAPTTDP1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074820-B GLP-1 receptor modulators 赛尔基因第二国际有限公司 2021-05-18 — — CN disclosed
CN-112457301-A Novel GLP-1 receptor modulators 赛尔基因第二国际有限公司 2021-03-09 — — CN disclosed
EP-3008056-B1 NOVEL GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-12-09 — — EP disclosed
EP-2791112-B1 CARBOXYLIC ACID DERIVATIVES COMPRISING FOUR CYCLES ACTING AS GLP-1 RECEPTOR MODULATORS FOR THERAPY OF DISEASES SUCH AS DIABETES CELGENE INT II SÀRL (CH) 2020-09-23 — — EP disclosed
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
Send feedback